Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07600424 · ClinicalTrials.gov registry record · NA
Transcutaneous Auricular Vagus Nerve Stimulation Treatment for Rosacea
A NA study, sponsored by Brigham and Women's Hospital.
- Not yet
- Registry status
- NA
- Development phase
- 10
- Enrollment target
NCT07600424 is a NA study that has not yet begun recruiting, run by Brigham and Women's Hospital. The registered enrollment target is 10 participants.
The verdict
NCT07600424, a NA study, has not yet begun recruiting, sponsored by Brigham and Women's Hospital.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
Study Summary
A single arm, pilot study among individuals with rosacea and at least moderate flushing or rednesss will be enrolled in a 4-week trial of taVNS. The particicpants will be followed for an additional 4-weeks following the intervention period to evaluate the durability of the results
Interventions
- DEVICE Transaricular vagus nerve stimulation (taVNS)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2026-06-01 |
| Est. Completion | 2028-02-28 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07600424
The ClinicalTrials.gov registry entry for NCT07600424 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Brigham and Women's Hospital, which has 937 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Transaricular vagus nerve stimulation (taVNS) is the first listed.
NCT07600424 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07600424 about?
NCT07600424 is a clinical study titled "Transcutaneous Auricular Vagus Nerve Stimulation Treatment for Rosacea". A single arm, pilot study among individuals with rosacea and at least moderate flushing or rednesss will be enrolled in a 4-week trial of taVNS. The particicpants will be followed for an additional 4-weeks following the intervention period to evaluate the durability of the results
What is the current status of trial NCT07600424?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 10 participants. The study started on 2026-06-01. Estimated completion is 2028-02-28.
What interventions are being tested in trial NCT07600424?
The interventions under investigation include: Transaricular vagus nerve stimulation (taVNS) (DEVICE).
Who is sponsoring clinical trial NCT07600424?
This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.